Liquidia Corp (LQDA)

$18.14 +0.12 (0.67%)
Market Cap 1.54B
Revenue (ttm) 14.00M
Net Income (ttm) -130.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -931.36%
Debt to Equity Ratio 2.83
Volume 1,345,700
Avg Vol 1,693,062
Day's Range N/A - N/A
Shares Out 85.49M
Stochastic %K 90%
Beta 0.04
Analysts Strong Sell
Price Target $30.70

Latest News on LQDA

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

Jun 2, 2025, 6:30 AM EDT - 4 days ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

These Analysts Boost Their Forecasts On Liquidia

May 28, 2025, 11:08 AM EDT - 9 days ago

These Analysts Boost Their Forecasts On Liquidia

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

May 28, 2025, 8:00 AM EDT - 9 days ago

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

May 23, 2025, 2:28 PM EDT - 14 days ago

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

May 12, 2025, 6:00 AM EDT - 26 days ago

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript

May 10, 2025, 9:29 PM EDT - 27 days ago

Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 8, 2025, 6:30 AM EDT - 4 weeks ago

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month

May 5, 2025, 4:06 PM EDT - 4 weeks ago

Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

May 2, 2025, 5:28 PM EDT - 5 weeks ago

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

May 1, 2025, 8:00 AM EDT - 5 weeks ago

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Arquitos Capital's Largest Holdings  For Q1 2025

Apr 30, 2025, 9:30 AM EDT - 5 weeks ago

Arquitos Capital's Largest Holdings  For Q1 2025

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 10:33 AM EDT - 2 months ago

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 2 months ago

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Mar 28, 2025, 9:30 AM EDT - 2 months ago

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 11:56 AM EDT - 2 months ago

Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 19, 2025, 6:30 AM EDT - 2 months ago

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Mar 12, 2025, 8:00 AM EDT - 3 months ago

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off

Nov 15, 2024, 10:20 AM EST - 7 months ago

Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off

Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 2:40 PM EST - 7 months ago

Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 13, 2024, 6:30 AM EST - 7 months ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Oct 7, 2024, 10:00 AM EDT - 8 months ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Oct 2, 2024, 6:00 AM EDT - 8 months ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Liquidia Corporation Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Oct 1, 2024, 11:00 AM EDT - 8 months ago

Liquidia Corporation Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Impacted Investors Are Encouraged To Contact The Schall Law Firm

Sep 30, 2024, 11:00 AM EDT - 8 months ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Impacted Investors Are Encouraged To Contact The Schall Law Firm

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

Sep 30, 2024, 8:00 AM EDT - 8 months ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Inquiry Into Liquidia Corporation

Sep 29, 2024, 11:00 AM EDT - 8 months ago

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Inquiry Into Liquidia Corporation

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Investors Are Invited To Contact The Schall Law Firm

Sep 28, 2024, 11:00 AM EDT - 8 months ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Investors Are Invited To Contact The Schall Law Firm

Investors Are Invited To Help The Schall Law Firm Investigate Whether Liquidia Corporation Violated Securities Laws

Sep 24, 2024, 11:00 AM EDT - 9 months ago

Investors Are Invited To Help The Schall Law Firm Investigate Whether Liquidia Corporation Violated Securities Laws

The Schall Law Firm Is Looking Into Liquidia Corporation For Securities Fraud And Shareholders With Losses Should Reach Out

Sep 23, 2024, 11:00 AM EDT - 9 months ago

The Schall Law Firm Is Looking Into Liquidia Corporation For Securities Fraud And Shareholders With Losses Should Reach Out

Liquidia Corporation May Have Defrauded The Public And The Schall Law Firm Wants Shareholders With Losses To Reach Out

Sep 21, 2024, 11:00 AM EDT - 9 months ago

Liquidia Corporation May Have Defrauded The Public And The Schall Law Firm Wants Shareholders With Losses To Reach Out

The Schall Law Firm Has Launched An Inquiry Into Liquidia Corporation For Violating Securities Laws And Affected Investors Should Participate

Sep 20, 2024, 11:00 AM EDT - 9 months ago

The Schall Law Firm Has Launched An Inquiry Into Liquidia Corporation For Violating Securities Laws And Affected Investors Should Participate

Liquidia Corporation Is Being Investigated For Securities Fraud And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

Sep 19, 2024, 11:00 AM EDT - 9 months ago

Liquidia Corporation Is Being Investigated For Securities Fraud And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

The Schall Law Firm Invites Investors To Join An Inquiry Into Liquidia Corporation For Violating Securities Laws

Sep 18, 2024, 11:00 AM EDT - 9 months ago

The Schall Law Firm Invites Investors To Join An Inquiry Into Liquidia Corporation For Violating Securities Laws

Liquidia Corporation Is Being Investigated For Securities Fraud And Affected Stakeholders Are Urged To Reach Out To The Schall Law Firm

Sep 17, 2024, 11:00 AM EDT - 9 months ago

Liquidia Corporation Is Being Investigated For Securities Fraud And Affected Stakeholders Are Urged To Reach Out To The Schall Law Firm

Court Finds United Therapeutics' Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

Sep 16, 2024, 9:41 AM EDT - 9 months ago

Court Finds United Therapeutics' Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

Liquidia Corporation May Have Engaged In Securities Fraud And Investors Are Urged To Join The Schall Law Firm's Investigation

Sep 15, 2024, 11:00 AM EDT - 9 months ago

Liquidia Corporation May Have Engaged In Securities Fraud And Investors Are Urged To Join The Schall Law Firm's Investigation

The Schall Law Firm Is Inquiring Into Liquidia Corporation's Questionable Practices And Shareholders Should Reach Out

Sep 14, 2024, 11:00 AM EDT - 9 months ago

The Schall Law Firm Is Inquiring Into Liquidia Corporation's Questionable Practices And Shareholders Should Reach Out

Liquidia Corporation May Have Violated Securities Regulations And The Schall Law Firm Urges Investors To Partake In An Investigation

Sep 13, 2024, 11:00 AM EDT - 9 months ago

Liquidia Corporation May Have Violated Securities Regulations And The Schall Law Firm Urges Investors To Partake In An Investigation

The Schall Law Firm Is Looking Into Whether Liquidia Corporation Engaged In Securities Fraud And Affected Shareholders Can Lend A Hand

Sep 12, 2024, 11:00 AM EDT - 9 months ago

The Schall Law Firm Is Looking Into Whether Liquidia Corporation Engaged In Securities Fraud And Affected Shareholders Can Lend A Hand

Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement

Sep 11, 2024, 8:26 AM EDT - 9 months ago

Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement